High RRN3 expression is associated with malignant characteristics and poor prognosis in pancreatic cancer

ConclusionHigh levels of RRN3 expression are associated with poor prognosis and cancer malignancy, such as proliferation, invasion ability, and chemosensitivity in pancreatic cancer. RRN3 targeting with anticancer drugs may be a promising therapeutic strategy to overcome refractory pancreatic cancer.

http://rd.springer.com/10.1007/s10147-023-02342-w

Source: International Journal of Clinical Oncology - July 1, 2023 Category: Cancer & Oncology Source Type: research